コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 of Crohn's disease, ulcerative colitis, and pouchitis.
2 t the intestinal microbiome of patients with pouchitis.
3 the microbiome and host transcriptome during pouchitis.
4 ission in patients with antibiotic-dependent pouchitis.
5 nd clinical outcome in patients with chronic pouchitis.
6 s open-labeled trial of antibiotic-dependent pouchitis.
7 tiating between irritable pouch syndrome and pouchitis.
8 on complication of this surgery, however, is pouchitis.
9 tis and chronic pouchitis and delay onset of pouchitis.
10 ther CD of the colon, ulcerative colitis, or pouchitis.
11 f quiescent ulcerative colitis and relapsing pouchitis.
12 Symptoms alone do not reliably diagnose pouchitis.
13 host-microbiome regulatory interface during pouchitis.
14 id not meet the PDAI diagnostic criteria for pouchitis.
15 provide long-term benefit for patients with pouchitis.
16 poor function (18 [30%]: 2 early, 16 late), pouchitis (7 [11%]: 2 early, 5 late) and miscellaneous (
17 2 carriage rate compared with those without pouchitis (72% vs. 45%) and Kaplan-Meier survival analys
19 dication for colectomy and the occurrence of pouchitis after ileal pouch-anal anastomosis formation.
20 1 receptor antagonist gene allele 2 predicts pouchitis after ileal pouch-anal anastomosis in ulcerati
23 own the benefits of a range of probiotics in pouchitis and in ulcerative colitis, although current ev
24 ccus salivarius prevent relapse of recurrent pouchitis and perhaps decrease the initial onset of pouc
26 potentially prevent and treat Crohn disease, pouchitis, and possibly ulcerative colitis, but optimal
27 y, risk factors, diagnosis and management of pouchitis, and pouch surveillance for neoplasia in patie
28 Crohn's disease, ulcerative colitis, and pouchitis are caused by overly aggressive immune respons
29 Crohn's disease, ulcerative colitis, and pouchitis are the result of continuous microbial antigen
31 s had a significantly increased incidence of pouchitis compared with noncarriers (log-rank test, 6.5)
32 be due to inflammatory conditions, including pouchitis, cuffitis, or Crohn's disease or noninflammato
33 ith irritable pouch syndrome from those with pouchitis, cuffitis, or Crohn's disease with a sensitivi
35 25% of patients with symptoms suggestive of pouchitis did not meet the PDAI diagnostic criteria for
37 doscopy with biopsy, with calculation of the pouchitis disease activity index in a prospective cross-
39 phic and disease activity data (based on the Pouchitis Disease Activity Index) and measured levels of
43 ive colitis, the treatment and prevention of pouchitis has become the one established indication for
44 's disease, ulcerative colitis, obesity, and pouchitis have been correlated with large-scale imbalanc
54 Patients were classified as either having pouchitis (PDAI score > or =7; N = 22) or as not having
56 Adult patients with antibiotic-dependent pouchitis received a 2-week course of various antibiotic
58 s often develop antibiotic-dependent form of pouchitis requiring long-term antibiotic therapy for rem
61 omise for physiologic, nontoxic treatment of pouchitis, ulcerative colitis, and acute infectious diar
62 ecalibacterium were reduced in patients with pouchitis vs controls; there was a negative correlation
63 le, and ciprofloxacin as optimal therapy for pouchitis, when preventive therapy with probiotics is no
64 olated ileal disease), perianal fistulae and pouchitis, whereas selected probiotic preparations preve
65 inflammation, particularly Crohn disease and pouchitis, whereas viral, bacterial, fungal, and protozo
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。